Citations Appearing in 1995

  1. Amantea, M.A., R.A. Bowden, A. Forrest, P.K. Working, M.S. Newman and R.D. Mamelok. Population pharmacokinetics and renal function-sparing effects of Amphotericin- B colloidal dispersion in patients receiving bone marrow transplants. Antimicrobial Agents and Chemotherapy 39:2042-2047, 1995.
  2. Bilello, J.A., P.A. Bilello, M. Prichard, T. Robins and G.L. Drusano. Reduction of the in-vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum alpha(1) acid glycoprotein. Journal of Infectious Diseases 171:546-551, 1995.
  3. Bjorkman, S., D.R. Wada, D.R. Stanski and W.F. Ebling. Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single tissue models. Journal of Pharmacokinetics and Biopharmaceutics 22:381-410, 1995.
  4. Boddy, A.V., M. Cole, A.D.J. Pearson and J.R. Idle. The kinetics of the auto-induction of Ifosfamide metabolism during continuous infusion. Cancer Chemotherapy and Pharmacology 36(1):53-60, 1995.
  5. Conley, B.A., S. Ohara, S.L. Wu, T.J. Melink, H. Parnes, E. Pardoe, M.J. Egorin and D.A. Vanecho. Phase I trial of Chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics. Cancer Chemotherapy and Pharmacology 37:139-149, 1995.
  6. Degraaf, S.S.N., H. Bloemhof, D.E.M.M. Vendrig and D.R.A. Uges. Vincristine disposition in children with acute lymphoblastic leukemia. Medical and Pediatric Oncology 24:235-240, 1995.
  7. Drusano, G.L., W.G. Liu, R. Perkins, A. Madu, C. Madu, M. Mayers and M.H. Miller. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of Ciprofloxacin from sparse data sets by using It2S, a population pharmacokinetic modeling program. Antimicrobial Agents and Chemotherapy 39:1683-1687, 1995.
  8. Dubovska, D., V.K. Piotrovskij, M. Gajdos, Z. Krivosikova, V. Spustova and T. Trnovec. Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses – a compartmental model. Methods and Findings in Experimental and Clinical Pharmacology 17:67-77, 1995.
  9. Ducharme, J., H. Fieger, M.P. Ducharme, S.K.W. Khalil and I.W. Wainer. Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects. British Journal of Clinical Pharmacology 40:127-133, 1995.
  10. Ebling, W.F., D.R. Wada and D.R. Stanski. From piecewise to full physiological pharmacokinetic modeling applied to thiopental disposition in the rat. Journal of Pharmacokinetics and Biopharmaceutics 22:259-292, 1995.
  11. Eisenberger, M.A., V.J. Sinibaldi, L.M. Reyno, R. Sridhara, D.I. Jodrell, E.G. Zuhowski, T.H. Tkaczuk, M.H. Lowitt, R.K. Hemady, S.C. Jacobs, D. Van Echo and M.J. Egorin. Phase-I and clinical evaluation of a pharmacologically guided regimen of Suramin in patients with hormone refractory prostate cancer. Journal of Clinical Oncology 13:2174- 2186, 1995.
  12. Elmansouri, S., M. Tod, M. Leclerq, O. Petitjean, G. Perret and M. Porthault. Time dependent and dose dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s). Drug Metabolism and Disposition 23:227-231, 1995.
  13. Erkmen, K., M.J. Egorin, L.M. Reyno, R. Morgan and J.H. Doroshow. Effects of storage on the binding of Carboplatin to plasma proteins. Cancer Chemotherapy and Pharmacology 35:254-256, 1995.
  14. Fletcher, C.V., W.K. Henry, S.E. Noormohamed, F.S. Rhame and H.H. Balfour. The effect of Cimetidine and Ranitidine administration with Zidovudine. Pharmacotherapy 15:701-708, 1995.
  15. Fouque, D., S.C. Peng and J.D. Kopple. Pharmacokinetics of recombinant human insulin-like growth factor I in dialysis patients. Kidney International 47:869-875, 1995.
  16. Gianni, L., C.M. Kearns, A. Giani, G. Capri, L. Vigano, A. Locatelli, G. Bonadonna and M.J. Egorin. Nonlinear pharmacokinetics, metabolism and pharmacodynamics of Paclitaxel in adult patients with solid tumors. Journal of Clinical Oncology 13:180-190, 1995.
  17. Glantz, M.J., H. Choy, C.M. Kearns, W. Akerley and M.J. Egorin. Weekly, Outpatient Paclitaxel and concurrent cranial irradiation in adults with brain tumors preliminary results and promising directions. Seminars in Oncology 22:26-32, 1996.
  18. Glantz, M.J., H. Choy, C.M. Kearns, P.C. Mills, L.U. Wahlberg, E.G. Zuhowski, P. Calabresi and M.J. Egorin. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. Journal of the National Cancer Institute 87:1077-1081, 1995.
  19. Houghton, J.A., P.J. Cheshire, C.L. Morton and C.F. Stewart. Potentiation of 5- Fluorouracil-Leucovorin activity by interferon-Alpha-2A in colon adenocarcinoma xenografts. Clinical Cancer Research 1(1):33-40, 1995.
  20. Judson, I.R. Pharmacokinetic modeling – a prelude to therapeutic drug monitoring for all cancer patients. European Journal of Cancer 31A:1733-1735, 1995.
  21. Kearns, C.M., C.P. Belani, K. Erkmen, M. Zuhowski, D. Hiponia, D. Zacharski, C. Engstrom, R. Ramanathan, M.R. Trenn, J. Aisner and M.J. Egorin. Pharmacokinetics of Paclitaxel and Carboplatin in combination. Seminars in Oncology 22:1-4, 1995.
  22. Landoni, M.F. and F.M. Cunningham. Determination of pharmacokinetics and pharmacodynamics of Flunixin in calves by use of pharmacokinetic-pharmacodynamic modeling. American Journal of Veterinary Research 56:786-794, 1995.
  23. Landoni, M.F., F.M. Cunningham and P. Lees. Pharmacokinetics and pharmacodynamics of Ketoprofen in calves applying Pk/Pd modeling. Journal of Veterinary Pharmacology and Therapeutics 18:315-324, 1995.
  24. Landoni, M.F. and P. Lees. Comparison of the anti-inflammatory actions of Flunixin and Ketoprofen in horses applying Pk/Pd modeling. Equine Veterinary Journal 27:247-256, 1995.
  25. Mari, A. Determination of the single pass impulse response of the body tissues with circulatory models. IEEE Transactions on Biomedical Engineering 42:304-312, 1995.
  26. Mckindley, D.S., T.C. Fabian, B.A. Boucher, M.A. Croce and K.G. Proctor. Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock. Archives of Surgery 130:1321-1329, 1995.
  27. Munkholm, P., H. Hey, S.N. Rasmussen and P.B. Johansen. Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers. European Journal of Drug Metabolism and Pharmacokinetics 19:337-341, 1995.
  28. Murry, D.J., W.R. Crom, W.E. Reddick, R. Bhargava and W.E. Evans. Liver volume as a determinant of drug clearance in children and adolescents. Drug Metabolism and Disposition 23:1110-1116, 1995.
  29. Murry, D.J., T. Synold, C.H. Pui and J.H. Rodman. Renal function and Methotrexate clearance in pediatric cancer patients. Pharmacotherapy 15:144-149, 1995.
  30. Noormohamed, S.E., W.K. Henry, F.S. Rhame, H.H. Balfour and C.V. Fletcher. Strategies for control of Zidovudine concentrations in serum. Antimicrobial Agents and Chemotherapy 39:2792-2797, 1995.
  31. Peng, B., A.V. Boddy, M. Cole, A.D.J. Pearson, E. Chatelut, H. Rubie and D.R. Newell. Comparison of methods for the estimation of Carboplatin pharmacokinetics in children. European Journal of Cancer 31(11):1804-1810, 1995.
  32. Piscitelli, S.C., A. Thibault, W.D. Figg, A. Tompkins, D. Headlee, R. Liebermann, D. Samid and C.E. Myers. Disposition of Phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. Journal of Clinical Pharmacology 35:368-373, 1995.
  33. Przepiorka, D., T. Madden, C. Ippoliti, Z. Estrov and M. Dimopoulos. Dosing of Thiotepa for myeloablative therapy. Cancer Chemotherapy and Pharmacology 37:155- 160, 1995.
  34. Rafi, I., G.A. Taylor, J.A. Calvete, A.V. Boddy, K. Balmanno, N. Bailey, M. Lind, A.H. Calvert, S. Wevver, R.C. Jackson, J. Johnston, N. Clendeninn and D.R. Newell. Clinical pharmacokinetic and pharmacodynamic studies with the non-classical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxy-5-(4-pyridylthio)- quinazoline dihychloride(AG337) given by 24 hour continuous intravenous infusion. Clinical Cancer Research 1(11):1275-1284, 1995.
  35. Reyno, L.M., M.J. Egorin, M.A. Eisenberger, V.J. Sinibaldi, E.G. Zuhowski and R. Sridhara. Development and validation of a pharmacokinetically based fixed dosing scheme for Suramin. Journal of Clinical Oncology 13:2187-2195, 1995.
  36. Sausville, E.A., D. Headlee, M. Stetlerstevenson, E.S. Jaffe, D. Solomon, W.D. Figg, J. Herdt, W.C. Kopp, H. Rager, S.M. Steinberg, V. Ghetie, J. Schindler, J. Uhr, R.E. Wittes and E.S. Vitetta. Continuous infusion of the anti-Cd22 immunotoxin IgG-Rfb4- Smpt-Dga in patients with B-cell lymphoma-A phase I study. Blood 85:3457-3465, 1995.
  37. Schwebke, K., C.V. Fletcher, E.P. Acosta and K. Henry. Pentamidine concentrations in a mother with AIDS and in her neonate. Clinical Infectious Diseases 20:1569-1570, 1995.
  38. Seidman, A.D., C. Hudis, A. Tiersten, M. Gollub, S. Barrett, T.J. Yao, J. Lepore, T. Gilewski, V. Currie, J. Crown, T. Hakes, J. Baselga, N. Sklarin, M.E. Moynihan, W. Tong, C. Kearns, M. Egorin, D. Sprigg and L. Norton. Phase II trial of Paclitaxel by three hour infusion as initial and as salvage chemotherapy for metastatic breast cancer. Journal of Clinical Oncology 13:2575-2581, 1995.
  39. Soefje, S.A., T. Madden, C. Herzog, N. Jaffe, J.B. Fano and E.S. Kleinerman. The effects of IL-1 on etoposide pharmacokinetics in patients with relapsed metastatic osteosarcoma. Pharmacotherapy 15:375, 1995.
  40. Soraci, A., E. Benoit and P. Delatour. Comparative metabolism of R(-)-Fenoprofen in rats and sheep. Journal of Veterinary Pharmacology and Therapeutics 18:167-171, 1995.
  41. Sowinski, K.M., B.S. Burlew and J.A. Johnson. Racial differences in sensitivity to the negative chronotropic effects of Propranolol in healthy men. Clinical Pharmacology and Therapeutics 57:678-683, 1995.
  42. Stute, N., W.L. Furman, M. Schell and W.E. Evans. Pharmacokinetics of recombinant human granulocyte macrophage colony stimulating factor in children after intravenous and subcutaneous administration. Journal of Pharmaceutical Sciences 84:824-828, 1995.
  43. Tod, M., C. Pobel, V. Legros, K. Louchahi, O. Petitjean, N. Brion and J.L. Garciamace. A Population Pharmacokinetic study of Alminoprofen penetration into synovial fluid. Biopharmaceutics and Drug Disposition 16:627-634, 1995.
  44. Uckun, F.M., W.E. Evans, C.J. Forsyth, K.G.Waddick, L.T. Ahlgren, L.M. Chelstrom, A. Burkhardt, J. Bolen and D.E. Myers. Biotherapy of B-cell precursor leukemia by targeting genistein to Cd19-associated tyrosine kinases. Science 267:886-891, 1995.
  45. Uckun, F.M., C.F. Stewart, G. Reaman, L.M. Chelstrom, J.H. Jin, M. Chandanlanglie, K.G. Waddick, J. White and W.E. Evans. In-vitro and in-vivo activity of Topotecan against human B-lineage acute lymphoblastic leukemia cells. Blood 85:2817-2828, 1995.
  46. Wang, Y.F. and R.J. Sawchuk. Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion. Journal of Pharmaceutical Sciences 84:871-876, 1995.
  47. Wedge, S.R., S. Laohavinij, G.A. Taylor, A. Boddy, A.H. Calvert and D.R. Newell. Clinical pharmacokinetics of the antipurine antifolate (6r)-5, 10-dideaza-5,6,7,8-tetrahydrofolic acid (Lometrexol) administered with an oral folic acid supplement. Clinical Cancer Research 1(12):1479-1486, 1995.
  48. Weissburg, R.P., P.W. Berman, J.L. Cleland, D. Eastman, F. Farina, S. Frie, A. Lim, J. Mordenti, T.T. Nguyen, M.R. Peterson, K. Yim and M.F. Powell. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharmaceutical Research 12(10):1439-1446, 1995.
  49. Williams, L.E., T.L. Odommaryon, A. Liu, A. Chai, A.A. Raubitschek, J.Y.C. Wong and D.Z. D’Argenio. On the correction for radioactive decay in pharmacokinetic modeling. Medical Physics 22:1619-1626, 1995.
  50. Wong, J.Y.C., L.E. Williams, D.M. Yamauchi, T. Odommaryon, J.M. Esteban, M. Neumaier, A.M. Wu, D.K. Johnson, F.J. Primus, J.E. Shively and A.A. Raubitschek. Initial experience evaluating (90)yttrium radio-labeled anticarcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial. Cancer Research 55:S5929- S5934, 1995.
  51. Youn, J.H., E.A. Gulve, E.J. Henriksen and J.O. Holloszy. Interactions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle. American Journal of Physiology – Regulatory Integrative and Comparative Physiology 36:R888-R894, 1995.